Skip to content
Sign in

BKYI · NASDAQ

BIO-key International (BKYI) Stock Price & Fundamentals

$994.27+0.39%+$3.83End-of-day price as of Oct 9, 2026

BIO-key International (BKYI) closed at $994.27 on Oct 9, 2026, up 0.39% from the previous close of $990.44.

Share price, past year

1Y +28.53%

52-week range $681.74 – $994.27. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$994.27
Sep 30, 2026$977.53
Aug 31, 2026$905.38
Jul 31, 2026$890.66
Jun 30, 2026$840.30
May 29, 2026$765.25
Apr 30, 2026$715.63
Mar 31, 2026$689.71
Feb 27, 2026$712.45
Jan 30, 2026$745.76
Dec 31, 2025$769.58
Nov 28, 2025$788.48
Oct 31, 2025$772.52

Key statistics

Market cap
$1.08B
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
$6.70M
Net income (TTM)
−$6.04M
Shares outstanding
1.1M
Dividend yield
—
52-week range
$681.74 – $994.27

BIO-key International's market cap is $1.08B, based on a share price of $994.27 and 1.1M shares outstanding as of Jun 30, 2026.

Financials

BIO-key International reported revenue of $5.94M for fiscal 2025, down 14.32% from fiscal 2024.

BIO-key International reported a net loss of $7.16M in fiscal 2025.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
BIO-key International annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$5.94M−14.3%−$7.16M−120.6%—−$4.68M
FY2024ended Dec 31, 2024$6.93M−10.6%−$4.30M−62.1%—−$2.93M
FY2023ended Dec 31, 2023$7.75M+10.5%−$8.52M−109.9%—−$3.79M
FY2022ended Dec 31, 2022$7.02M+37.3%−$11.91M−169.7%—−$6.31M
FY2021ended Dec 31, 2021$5.11M+80.3%−$5.07M−99.1%−$0.65−$9.02M
FY2020ended Dec 31, 2020$2.84M+25.1%−$9.67M−341.0%−$2.08−$4.99M
FY2019ended Dec 31, 2019$2.27M−43.9%−$14.59M−643.4%−$8.21−$1.88M
FY2018ended Dec 31, 2018$4.04M−35.8%−$6.87M−169.8%−$0.73−$1.67M
FY2017ended Dec 31, 2017$6.30M+111.8%−$4.28M−67.8%−$0.76−$2.63M
FY2016ended Dec 31, 2016$2.98M—−$4.19M−140.8%−$0.89−$4.50M
BIO-key International quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$1.92M−$576.85K—
Q1 FY2026ended Mar 31, 2026$2.15M−$205.04K—
Q4 FY2025ended Dec 31, 2025$1.08M−$4.29M—
Q3 FY2025ended Sep 30, 2025$1.55M−$964.85K—
Q2 FY2025ended Jun 30, 2025$1.70M−$1.17M—
Q1 FY2025ended Mar 31, 2025$1.61M−$736.55K—
Q4 FY2024ended Dec 31, 2024$1.46M−$1.38M—
Q3 FY2024ended Sep 30, 2024$2.14M−$738.96K—

Company profile

Name
BIO-key International, Inc.
Ticker
BKYI
Exchange
NASDAQ
Industry (SEC SIC)
Services-Prepackaged Software
Headquarters
101 Crawfords Corner Rd, Suite 4116, Holmdel, NJ 07733
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001019034

Recent SEC filings

Frequently asked questions

What is BIO-key International's stock price?

BIO-key International (BKYI) closed at $994.27 on Oct 9, 2026, up 0.39% from the previous close of $990.44.

What is BIO-key International's market cap?

BIO-key International's market cap is $1.08B, based on a share price of $994.27 and 1.1M shares outstanding as of Jun 30, 2026.

How much revenue does BIO-key International make?

BIO-key International reported revenue of $5.94M for fiscal 2025, down 14.32% from fiscal 2024.

Does BIO-key International pay a dividend?

BIO-key International's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from BIO-key International, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures